Programme

Welcome and introduction
Dr Ton Nicolai, EUROCAM spokesperson

Welcome key note: The policy of integration of Complementary Medicine in public health of the Tuscany Region
Dr Elio G. Rossi, Head of the Coordination Center of Complementary Medicine – ASL Tuscany North West

Methodologies and results of the CAM-JPIAMR project
Presentation of results of the CAM-JPIAMR project: Systematic review of systematic reviews of CAM treatment of respiratory tract infections (RTIs), expert knowledge survey conducted in
four European countries, Decision Making Tool for CAM treatment of URTIs.
Dr Erik Baars, Professor in Anthroposophic Healthcare at the University of Applied Sciences, Leiden, Netherlands; Senior researcher in Healthcare, Louis Bolk Institute, Department of
Health and Nutrition, Netherlands
Dr Merlin Willcox, Academic Clinical Lecturer at the Department of Primary Care and Population Sciences at the University of Southampton, United Kingdom
Dr Esther van der Werf-Kok, Lecturer in Epidemiology of Primary Care Infectious Diseases, University of Bristol, United Kingdom

Questions and Answers understanding the methodologies and results
Dr David Martin, Director of the Institute of Integrative Medicine and Chair of Medical
Theory, Integrative and Anthroposophic Medicine at the University of Witten-Herdecke;
Professor of Paediatrics at Tübingen University, Senior Consultant for General Paediatrics,
Paediatric Endocrinology, Diabetology, and Oncology at the Filderklinik.
Dr Erik Baars, Dr Merlin Willcox and Dr Esther van der Werf-Kok (see above)

Panel and discussion: Immediate next steps to be achieved by the end of 2018
Testing of Decision Making Tool prototype with stakeholders, implementation/dissemination
strategies, organisational development of CAM DMTs for infections
Dr Roman Huber, Professor of Internal Medicine and Gastroenterology at the University of
Freiburg, Germany
Dr Klaus von Ammon, Researcher at the Institute of Complementary Medicine IKOM,
University of Berne, Switzerland
Dr Erik Baars, Dr Esther van der Werf-Kok, Dr Merlin Willcox, Dr David Martin (see above)

Panel and discussion: Adding value to the European AMR policy – vision for the next 5 years
Dr Dominique Monnet, Head of the Antimicrobial Resistance & Healthcare-Associated
Infections Programme at the European Centre for Disease Prevention and Control (ECDC)
Dr Philippe Hartemann, Professor in Public Health at Lorraine University in Nancy, France
Ms Rose Gallagher MBE, Professional Lead Infection Prevention and Control/AMR at the Royal
College of Nursing, United Kingdom
Dr Erik Baars, Dr Elio G. Rossi (see above)

Feedback from public health stakeholders and open discussion
Presentations by
Dr Dominique Monnet (see above)
Dr Philippe Hartemann (see above)
Ms Nina Renshaw, Secretary-General, European Public Health Alliance
Mr Robert Johnstone, Board Member of European Forum for Good Clinical Practice (EFGHP),
Health Quality Improvement Partnership (HQIP) and International Foundation for Integrated
Care (IFIC)